Big Tobacco’s market valuation has seen a significant boost in 2024, driven largely by growing investor confidence in smokeless nicotine products, despite the ongoing decline in traditional cigarette consumption. Companies such as Philip Morris International (PMI) and British American Tobacco (BAT) have experienced notable increases in their stock prices this year, suggesting a shift in market expectations toward the long-term potential of alternative nicotine offerings.

Philip Morris International’s market capitalization has doubled since the beginning of 2024, rising by approximately $134 billion. A considerable portion of this gain reflects heightened optimism about the company’s nicotine pouch product Zyn and heated tobacco device IQOS. According to analysts’ forecasts, earnings for PMI from 2026 to 2032 increased by $7 billion cumulatively since the start of the year. However, the majority of the valuation increase stems from projected cash flows expected beyond that period, highlighting strong investor belief in the sustained momentum of these products over the long term.

Similarly, British American Tobacco has seen its stock price double since early 2024. This rise corresponds to a roughly £50 billion increase in the market’s assessment of its future value, implying that investors are increasingly viewing nicotine as a growth sector despite shrinking cigarette volumes.

Regulatory developments in the United States have played an important role in supporting this positive outlook. The US Food and Drug Administration (FDA) recently authorized Philip Morris to market Zyn as a product that is safer than combustible cigarettes. Additionally, in May, the FDA allowed certain products to launch commercially even as they await full regulatory approval. The vaping industry may also be benefiting from these changes, with enhanced enforcement against imported Chinese products steering consumers toward approved, mainstream tobacco companies.

Nevertheless, some industry watchers caution that the current favorable regulatory environment for smokeless nicotine products could shift, particularly with future changes in US administration. European regulators are also considering stricter controls if alternative nicotine products appear to attract new users who might not have otherwise engaged in nicotine consumption.

Despite the ongoing challenges faced by traditional cigarette sales, the data reflects a marked transition in nicotine consumption patterns. Between 2010 and 2024, cigarette volumes fell by approximately 770 billion combustible “stick equivalents,” while alternative nicotine product volumes surged by nearly 11 trillion units worldwide.

While uncertainties remain, the tobacco industry’s recent market performance suggests that the prospect of decline may be receding. Instead, investors are placing growing value on the companies' capacity to innovate and capitalize on the expanding market for smokeless nicotine products.